NEFL and Alzheimer disease: The role of NfL as a biomarker has been established in conditions such as multiple sclerosis (MS), Alzheimer’s disease (AD), frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), atypical parkinsonian disorders (APD), and traumatic brain injury (TBI).